Research Article

Plasma Osteoprotegerin Correlates with Stroke Severity and the Occurrence of Microembolic Signals in Patients with Acute Ischemic Stroke

Table 1

Clinical characteristics of all participants.

VariablesLAA patients ()Controls () valueAdjusted OR (95% CI) value

Age (years)0.0571.052 (1.012-1.093)0.010
Sex, male, (%)81 (63.8)29 (51.8)0.1276.020 (1.681-21.563)0.006
Hypertension, (%)98 (77.2)23 (41.1)<0.0113.866 (3.075-62.530)0.001
Diabetes, (%)38 (29.9)10 (17.9)0.087
CAD, (%)26 (20.5)12 (21.4)0.883
Smoking, (%)66 (52.0)14 (25.0)0.0015.538 (0.569-53.884)0.140
Alcohol consumption, (%)62 (48.8)16 (28.6)0.0110.610 (0.057-6.571)0.684
TG (mmol/l)0.097
TC (mmol/l)0.09
HDL (mmol/l)<0.010.105 (0.017-0.643)0.015
LDL (mmol/l)0.057
GLU (mmol/l)0.0071.203 (0.928-1.559)0.163
hs-CRP (mg/l)0.0141.010 (0.990-1.029)0.330
OPG (pg/ml)<0.0011.002 (1.001-1.003)<0.001

CAD: coronary artery disease; TG: triglycerides; TC: total cholesterol; HDL: high-density lipoprotein, LDL: low-density lipoprotein; hs-CRP: high-sensitivity C-reactive protein; GLU: fasting blood glucose; OPG: osteoprotegerin; OR: odds ratio; CI: confidence interval; OR: adjusted for significant risk factors.